Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon

Parasitology Research

Volumn 113, Issue 6, 2014, Pages 2239-2250

  Zhang, Weidong ^a   Ahmad, Gul ^b   Le, Loc ^a   Rojo, Juan U ^a   Karmakar, Souvik ^a   Tillery, Kory A ^a   Torben, Workineh ^c   Damian, Raymond T ^d   Wolf, Roman F ^e   White, Gary L ^e   Carey, David W ^e   Carter, Darrick ^f,g   Reed, Steven G ^f   Siddiqui, Afzal A ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b PERU STATE COLLEGE   (United States)

^c TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^d UNIVERSITY OF GEORGIA   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f INFECTIOUS DISEASE RESEARCH INSTITUTE   (United States)

^g PAI Life Sciences   (United States)

Author keywords

Baboon; Calpain; Longevity of antibody responses; Nonhuman primate; Prophylactic vaccine; Schistosoma; Schistosomiasis; Sm p80; Transplacental antibodies transfer

Indexed keywords

DNA VACCINE; GLA SE VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; RECOMBINANT SM P80 VACCINE; RECOMBINANT VACCINE; SCHISTOSHIELD; SCHISTOSOMA VACCINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CERCARIA; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FOLLOW UP; HELMINTHIASIS; LONGEVITY; MOUSE; NONHUMAN; PLACENTAL TRANSFER; PRIORITY JOURNAL; SCHISTOSOMIASIS MANSONI; UMBILICAL CORD BLOOD; VACCINATION;

CRICETINAE; MUS; PAPIO; PRIMATES; RODENTIA; SCHISTOSOMA;

ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, HELMINTH; BIOMPHALARIA; CRICETINAE; FEMALE; FETAL BLOOD; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN G; MICE; PAPIO; PREGNANCY; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINATION; VACCINES; VACCINES, DNA;

EID: 84903816420     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-014-3879-8     Document Type: Article

References (40)

1. Ahmad G, Zhang W, Torben W, Ahrorov A, Damian RT, Wolf RF, White GL, Carey DW, Mwinzi PN, Ganley-Leal L, Kennedy RC, Siddiqui AA (2011) Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Smp80 in Human serum samples from an area where schistosomiasis is endemic. J Infect Dis 204:1437-1449
2. Ahmad G, Zhang W, Torben W, Damian RT, Wolf RF, White GL, Chavez-Suarez M, Kennedy RC, Siddiqui AA (2009a) Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model. Vaccine 27:2830-2837
3. Ahmad G, Zhang W, Torben W, Haskins C, Diggs S, Noor Z, Le L, Siddiqui AA (2009b) Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine. Parasitol Res 105:1767-1777
4. Attallah AM, Ghanem GE, Ismail H, El Waseef AM (2003) Placental and oral delivery of Schistosoma mansoni antigen from infectedmothers to their newborns and children. Am J Trop Med Hyg 68:647-651 (Pubitemid 38235090)
5. Beaumier CM, Gillespie PM, Hotez PJ, Bottazzi ME (2013) New vaccines for neglected parasitic diseases and dengue. Transl Res 162:144-155
6. Bergquist NR, Leonardo LR, Mitchell GF (2005) Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? Trends Parasitol 21:112-117 (Pubitemid 40269774)
7. Bergquist R, Al-Sherbiny M, Barakat R, Olds R (2002) Blueprint for schistosomiasis vaccine development. Acta Trop 82:183-192 (Pubitemid 34520460)
8. Carter D, Reed SG (2010) Role of adjuvants in modeling the immune response. Curr Opin HIVAIDS 5:409-413
9. Clark EH, Silva CJ, Weiss GE, Li S, Padilla C, Crompton PD, Hernandez JN, Branch OH (2012) Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory. Infect Immun 80:1583-1592
10. Elgueta R, de Vries VC, Noelle RJ (2010) The immortality of humoral immunity. Immunol Rev 236:139-150
11. Gabriel S, De BJ, Phiri IK, Masuku M, Riveau G, Schacht AM, Deelder AM, Van Dam GJ, Vercruysse J (2002) Transplacental transfer of schistosomal circulating anodic antigens in cows. Parasite Immunol 24:521-525 (Pubitemid 36560793)
12. Gabriel S, Geldhof P, Phiri IK, Cornillie P, Goddeeris BM, Vercruysse J (2005) Placental transfer of immunoglobulins in cattle infected with Schistosoma mattheei. Vet Immunol Immunopathol 104:265-272 (Pubitemid 40269884)
13. Hotez PJ, Kamath A (2009) Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl Trop Dis 3:e412
14. Ireton GC, Reed SG (2013) Adjuvants containing natural and synthetic Toll-like receptor 4 ligands. Expert Rev Vaccines 12:793-807
15. Jenkins-Holick DS, Kaul TL (2013) Schistosomiasis. Urol Nurs 33:163-170
16. Karmakar S, Zhang W, Ahmad G, Torben W, Alam MU, Le L, Damian RT, Wolf RF, White GL, Carey DW, Carter D, Reed SG, Siddiqui AA (2014a) Cross-species protection: Schistosoma mansoni Smp80 vaccine confers protection against Schistosoma haematobium in hamsters and baboons. Vaccine 32:1296-1303
17. Karmakar S, Zhang W, Ahmad G, Torben W, Alam MU, Le L, Damian RT, Wolf RF, White GL, Carey DW, Carter D, Reed SG, Siddiqui AA (2014b) Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons. J Infect Dis. doi:10.1093/infdis/jiu031
18. King CH (2010) Parasites and poverty: the case of schistosomiasis. Acta Trop 113:95-104
19. Kitphati R, Pooruk P, Lerdsamran H, Poosuwan S, Louisirirotchanakul S, Auewarakul P, Chokphaibulkit K, Noisumdaeng P, Sawanpanyalert P, Puthavathana P (2009) Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans. Clin Vaccine Immunol 16:978-981
20. Komegae EN, Grund LZ, Lopes-Ferreira M, Lima C (2013a) The longevity of Th2 humoral response induced by proteases natterins requires the participation of long-lasting innate-like B cells and plasma cells in spleen. PLoS One 8:e67135
21. Komegae EN, Grund LZ, Lopes-Ferreira M, Lima C (2013b) TLR2, TLR4 and the MyD88 signaling are crucial for the in vivo generation and the longevity of long-lived antibody-secreting cells. PLoS One 8:e71185
22. McManus DP, Loukas A (2008) Current status of vaccines for schistosomiasis. Clin Microbiol Rev 21:225-242 (Pubitemid 351160017)
23. Mo AX, Agosti JM, Walson JL, Hall BF, Gordon L (2014) Schistosomiasis elimination strategies and potential role of a vaccine in achieving global health goals. Am J Trop Med Hyg 90:54-60
24. Novato-Silva E, Gazzinelli G, Colley DG (1992) Immune responses during human Schistosomiasis mansoni. XVIII. Immunologic status of pregnant women and their neonates. Scand J Immunol 35:429-437
25. Palmeira P, Costa-Carvalho BT, Arslanian C, Pontes GN, Nagao AT, Carneiro-Sampaio MM (2009) Transfer of antibodies across the placenta and in breast milk from mothers on intravenous immunoglobulin. Pediatr Allergy Immunol 20:528-535
26. Parker M, Allen T (2011) Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda. Health Res Policy Syst 9:3
27. Peroni DG, Chirumbolo S, Veneri D, Piacentini GL, Tenero L, Vella A, Ortolani R, Raffaelli R, Boner AL (2013) Colostrum-derived B and T cells as an extra-lymphoid compartment of effector cell populations in humans. J Matern Fetal Neonatal Med 26:137-142
28. Prichard RK, Basanez MG, Boatin BA, McCarthy JS, Garcia HH, Yang GJ, Sripa B, Lustigman S (2012) A research agenda for helminth diseases of humans: intervention for control and elimination. PLoS Negl Trop Dis 6:e1549
29. Reed SG, Orr MT, Fox CB (2013) Key roles of adjuvants in modern vaccines. Nat Med 19:1597-1608
30. Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuente LA, Garba A, Mohammed KA, Schur N, Person B, Colley DG, Utzinger J (2013) Time to set the agenda for schistosomiasis elimination. Acta Trop 128:423-440
31. Sabarth N, Savidis-Dacho H, Schwendinger MG, Bruhl P, Portsmouth D, Crowe BA, Kistner O, Barrett PN, Kreil TR, Howard MK (2012) A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination. Vaccine 30:5533-5540
32. Siddiqui AA, Pinkston JR, Quinlin ML, Saeed Q, White GL, Shearer MH, Kennedy RC (2005) Characterization of the immune response to DNAvaccination strategies for schistosomiasis candidate antigen, Sm-p80 in the baboon. Vaccine 23:1451-1456 (Pubitemid 40164704)
33. Skerry CM, Mahon BP (2011) A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. Clin Vaccine Immunol 18:187-193
34. Steinhagen F, Kinjo T, Bode C, Klinman DM (2011) TLR-based immune adjuvants. Vaccine 29:3341-3355
35. Taillardet M, Haffar G, Mondiere P, Asensio MJ, Pleau-Pison T, Burdin N, Defrance T, Genestier L (2010) Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine. J Infect Dis 202:470-479
36. Terer CC, Bustinduy AL, Magtanong RV, Muhoho N, Mungai PL, Muchiri EM, Kitron U, King CH, Mutuku FM (2013) Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic Communities in Kenya: a cross-sectional study. PLoS Negl Trop Dis 7:e2106
37. Torben W, Ahmad G, Zhang W, Nash S, Le L, Karmakar S, Siddiqui AA (2012) Role of antibody dependent cell mediated cytotoxicity (ADCC) in Sm-p80-mediated protection against Schistosoma mansoni. Vaccine 30:6753-6758
38. Torben W, Ahmad G, Zhang W, Siddiqui AA (2011) Role of antibodies in Sm-p80-mediated protection against Schistosoma mansoni challenge infection in murine and nonhuman primate models. Vaccine 29:2262-2271
39. Vujanic A, Snibson KJ, Wee JL, Edwards SJ, Pearse MJ, Scheerlinck JP, Sutton P (2012) Long-term antibody and immune memory response induced by pulmonary delivery of the influenza Iscomatrix vaccine. Clin Vaccine Immunol 19:79-83
40. Zhang W, Ahmad G, Torben W, Noor Z, Le L, Damian RT, Wolf RF, White GL, Chavez-Suarez M, Podesta RB, Kennedy RC, Siddiqui AA (2010) Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. J Infect Dis 201:1105-1112